Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Lilly revenue beats forecasts, drugmaker raises 2016 profit view
April 26 (Reuters) - Eli Lilly and Co on Tuesday reported sales above Wall Street expectations and slightly raised its profit view for the full year, citing a tax benefit.
The U.S. drugmaker said it had net income of $440 million, or 41 cents per share in the first quarter. That compared with $530 million, or 50 cents per share, in the year-earlier period.
Excluding special items, Lilly earned 83 cents per share, below the average analyst estimate of $0.85 per share compiled by Thomson Reuters I/B/E/S. It attributed the profit miss to the impact of the stronger dollar.
Company revenue rose 5 percent to $4.87 billion, topping Wall Street expectations of $4.82 billion.
(Reporting by Ransdell Pierson Editing by W Simon)
Terms and Privacy Policy